Increased serum S100B protein in schizophrenia: a study in medication-free patients
- 1 January 2001
- journal article
- Published by Elsevier in Journal of Psychiatric Research
- Vol. 35 (1) , 11-14
- https://doi.org/10.1016/s0022-3956(01)00003-6
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Decreased S100-beta protein in schizophrenia: preliminary evidenceSchizophrenia Research, 2000
- Extracellular S100B protein modulates ERK in astrocyte culturesNeuroReport, 2000
- Mind GlueArchives of General Psychiatry, 2000
- Functional roles of S100 proteins, calcium-binding proteins of the EF-hand typeBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1999
- A Follow-up Magnetic Resonance Imaging Study of SchizophreniaArchives of General Psychiatry, 1998
- A specific and sensitive ELISA for measuring S-100b in cerebrospinal fluidJournal of Immunological Methods, 1997
- Schizophrenia as a membrane lipid disorder which is expressed throughout the bodyProstaglandins, Leukotrienes & Essential Fatty Acids, 1996
- Cerebrospinal fluid and serum levels of neuron-specific enolase in patients with schizophreniaPsychiatry Research, 1992
- Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease.Proceedings of the National Academy of Sciences, 1989
- Impairment of the Blood-Brain Barrier as an Aetiological Factor in Paranoid PsychosisThe British Journal of Psychiatry, 1982